• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CEFALY TECHNOLOGY CEFALY DEVICE; STIMULATOR, NERVE, ELECTRICAL, TRANSCUTANEOUS, FOR MIGRAINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CEFALY TECHNOLOGY CEFALY DEVICE; STIMULATOR, NERVE, ELECTRICAL, TRANSCUTANEOUS, FOR MIGRAINE Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Visual Impairment (2138); Confusion/ Disorientation (2553); Unspecified Ear or Labyrinth Problem (4474)
Event Date 05/30/2021
Event Type  Injury  
Event Description
I have suffered from episodic migraines for the last 20 years.Most of my migraines start directly above my right eyebrow, a branch of the trigeminal nerve.Upon learning about the fda approved without a prescription cefaly device (a trigeminal nerve stimulator), i decided to give it a test since there was a 60-day trial.I purchased the product on (b)(6) and i used the product between 8 and 10 times both in the acute and preventative settings over the course of the next 30 days.I started to notice i was experiencing fluctuating bilateral ear fullness that would last a few hours a day but chalked that up to seasonal allergies.The ear fullness continued to get worse over time at which point i stopped using the cefaly as regularly in the first 2 weeks after receiving the device.I only used it 2 times after (b)(6), a 60-minute session on (b)(6) and a 20-minute session on (b)(6).By the (b)(6), i started to notice severe brain fog, vision sensitivity and worsening constant ear fullness that never went away.Cefaly's medical team claimed i may have placed the device too close to the eyebrows despite what their instructional videos show which might result in higher stimulation to a dense concentration of nerves as they exit the head.Nowhere was it explained in the video or packet that placing the device 1/4 of an inch too low could result in permanent damage.Now, 2 months later, (b)(6) in medical bills, a brain mri and ct and numerous doctors visits, i am still dealing with these problems.The fda should pull the cefaly off the market and definitely not make it available without a prescription until more extensive research has been done.Fda safety report id # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CEFALY DEVICE
Type of Device
STIMULATOR, NERVE, ELECTRICAL, TRANSCUTANEOUS, FOR MIGRAINE
Manufacturer (Section D)
CEFALY TECHNOLOGY
MDR Report Key12238890
MDR Text Key264093537
Report NumberMW5102802
Device Sequence Number1
Product Code PCC
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 07/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received07/27/2021
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Disability;
Patient Age33 YR
Patient Weight70
-
-